Winter storm warnings include northeast Twin Cities

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Last month the Food and Drug Administration announced that it would 

remove its warning on hormone-based products

As women age, most will experience changes linked to the stop of their monthly menses, including hot flashes, bone density loss and sleep problems. But in the past two decades a strong “black-box warning” has scared many women off from seeking relief in hormone creams, patches, pills and other treatments. 

The warning was added following a landmark study that linked hormone therapy to an increased risk for cancer and cardiovascular problems. Now the FDA says the risks were overblown for most women. 

Coming up at 9 a.m. on Wednesday, MPR News guest host Catharine Richert talks about the FDA’s change, the risks and benefits of hormone therapy and what women should consider as they decide whether to try it. 

What questions or concerns do you have about hormone therapy for menopause? If you use hormone therapy, what difference has it made in your symptoms? And what other ways of managing menopause symptoms seem to help?  

Call us during the 9 a.m. hour at 651-227-6000 or 800-242-2828.

Subscribe to the MPR News with Angela Davis podcast on:

Health

Shows

MPR News with Angela Davis

Host

Author

Coming up at 9 a.m. on Wednesday, MPR News guest host Catharine Richert talks about the FDA’s decision to remove warnings on hormone therapies to treat menopause symptoms. 

New thinking on menopause and hormone therapy

Go Deeper.

Like this?